Acupoint Stimulation Improves Cognition Under Hypoxia

NCT ID: NCT06521632

Last Updated: 2024-07-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-07-30

Study Completion Date

2025-05-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Cognitive impairment is common in people who suffer from hypoxia. Acupuncture and related techniques can be used to improve hypoxia and treat cognitive impairment. In this trial the effect of transcutaneous electrical acupoint stimulation on cognitive impairment in people under hypoxia will be investigated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cognition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
The stimulator is put in an opaque box

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

transcutaneous electrical acupoint stimulation

Electrodes are placed at acupoints and connected to the stimulators. Electrical stimulation is given for 2 hours

Group Type EXPERIMENTAL

transcutaneous electrical acupoint stimulation

Intervention Type OTHER

Electrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given for 2 hours.

Control

Electrodes are placed at acupoints but no electrical stimulation is given

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transcutaneous electrical acupoint stimulation

Electrodes are placed at acupoints and connected to the stimulator. Electrical stimulation is given for 2 hours.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male, age from 18 to 50 years

Exclusion Criteria

* cardiopulmonary dysfunction;
* History of severe respiratory, circulatory, digestive, blood, ear-nose-throat system diseases;
* A history of fever or respiratory infection within the last two weeks;
* Drinking alcohol or poor sleep within the last 24 hours
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhihong LU

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Zhihong LU

Associate professor

Responsibility Role SPONSOR_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Xijing Hospital

Xi'an, Shaanxi, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Zhihong Lu

Role: CONTACT

+8613891975018

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhihong Lu

Role: primary

+8613891975018

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XJH-A-20240319

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of TEAS on POCD
NCT04338555 COMPLETED NA
Multiple Study of Electroaccpuncture in ARDS
NCT06278675 NOT_YET_RECRUITING NA